The tumor suppressive role of GAS5 is supported by the identification of genetic susceptibility of its genomic locus, 1q25, to several cancers, including melanoma [150], prostate cancer [151], breast cancer [152,153], colorectal cancer [154] and B-cell lymphoma [155]. The gene discussed is GAS5; the disease is breast cancer.